Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Healthcare: MannKind's Back from the Brink

  • Broadcast in Finance
Industry Focus

Industry Focus

×  

Follow This Show

If you liked this show, you should follow Industry Focus.
h:899941
s:10966941
archived

A new cash lifeline from United Therapeutics buys the diabetes drugmaker more time to increase sales of its inhaled insulin. Also, make-or-break news is fast approaching for cardiovascular drugmaker, Amarin. MNKD, UTHR, AMRN

Comments